secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEXX LABORATORIES INC /DE (IDXX)
CIK:        0000874716
Form:       8-K
Filed at:   2021-12-09T23:59:59+00:00
Accession:  0001193125-21-352679
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEXX enters $1B revolving credit facility with extended maturity and lower rates
--------------------------------------------------------------------------------

- Fourth amended & restated credit agreement provides $1B unsecured revolver with $250M accordion feature.
- Maturity extended to December 9, 2026 (from 2020 agreement's 3-year term).
- Interest rate margins reduced; pricing (LIBOR + 0.875–1.375%) based on consolidated leverage ratio.
- New borrowers added: IDEXX Laboratories B.V. (Netherlands) and IDEXX Laboratories GmbH (Switzerland).
- Proceeds for general corporate purposes; commitment fee on unused portion ranges 0.075–0.250%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874716/000119312521352679/0001193125-21-352679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874716/000119312521352679/d264618d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-352679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer